Short answer
Evolent Health, Inc. (EVH) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $496M (up 2.6% year over year) with net income of −$27M.
Q1 2026 key financials · XBRL
- Revenue
- $496M
- +2.6% YoY
- Net income
- −$27M
- +58.8% YoY
- Operating margin
- -2.1%
- EPS (diluted)
- −$0.24
- +61.9% YoY
Source: XBRL data from the Evolent Health, Inc. (EVH) Q1 2026 10-Q on SEC EDGAR. USD.
Evolent Health, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- MD&A introductory disclosure only; no quarterly revenue, profitability, segment, cash-flow, or outlook figures provided
Risk Factors
- No Risk Factors section provided in the submitted excerpt
- New retention awards totaling $1.89 million create executive retention-cost exposure
- Awards vest in installments on December 31, 2026 and July 1, 2027
- Continued employment conditions create potential disruption if covered executives depart before retention dates
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Evolent Health, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.